PASADENA,
Calif.--(BUSINESS WIRE)--Dec. 8, 2005--Arrowhead
Research Corporation (Nasdaq: ARWR), a diversified
nanotechnology company, announced today that
wholly owned subsidiary NanoPolaris, Inc. has
assembled a portfolio of intellectual property
to facilitate and enable the manufacture of nanotube-based
products. NanoPolaris has exclusively licensed
U.S. patents and patent applications covering
technologies developed at:
-- California Institute of Technology
-- Duke University
-- The Pennsylvania State University
-- Rensselaer Polytechnic Institute
-- Tsinghua University at Beijing
-- University at Buffalo
-- University of California, Los Angeles
-- University of Toronto
"We believe carbon nanotubes will create a
manufacturing revolution comparable to what plastics
did for materials and silicon did for electronics," said
R. Bruce Stewart, Arrowhead's Chairman. "We
are taking the lead in consolidating the fragmented
patent landscape and working with manufacturers to
integrate these materials into their end products."
It is widely believed that carbon nanotubes' unique
electrical, mechanical and thermal properties can
be harnessed to substantially improve a variety of
products, including semiconductor devices, television
displays, solar cells, health care products and materials
used in everything from automobiles to baseball bats.
Numerous companies are now seeking to develop scaled
manufacturing techniques to incorporate nanotubes
into their products.
"This portfolio of key patents and patent applications
could be widely employed by different companies across
many industries," said Leon Ekchian, President
of Arrowhead. "NanoPolaris will not itself engage
in manufacturing. Rather, it will provide a necessary
and convenient patent toolbox to corporations planning
to integrate nanotubes into their end products."
NanoPolaris will seek to generate revenue by licensing
intellectual property to customers who will utilize
nanotube technology in their products. NanoPolaris
now controls commercialization of issued patents
and patent applications claiming nanotube compositions
of matter and general manufacturing techniques such
as chemical vapor deposition synthesis, plasma chemical
vapor deposition synthesis, purification, solubilization,
separation of certain types of tubes, coating, functionalization
and manipulation.
About Arrowhead Research Corporation
Arrowhead Research Corporation ( www.arrowheadresearch.com )
is a diversified nanotechnology company structured
to commercialize products expected to have revolutionary
impacts on a variety of industries, including materials,
electronics, life sciences, and energy.
There are three strategic components to Arrowhead's
business model:
--
Outsourced R&D Program: Arrowhead identifies
patented or patent-pending technologies at universities
or government labs and funds additional development
of those technologies in exchange for exclusive rights
to commercialize the resulting prototypes. Leveraging
the resources and infrastructure of these institutions
provides Arrowhead with a highly cost-effective development
pipeline. Currently, Arrowhead is supporting efforts
in stem cell technology, and nanosensors at the California
Institute of Technology and Stanford University.
-- Commercialization Program: After prototypes have
been sufficiently developed in the laboratories,
Arrowhead forms or acquires majority-owned subsidiaries
to commercialize the technology and provides the
subsidiaries with strategic, managerial, and operational
support. At present, Arrowhead owns majority interest
in subsidiaries commercializing diverse technologies,
including anti-cancer drugs, RNAi therapeutics, and
compound semiconductor materials.
-- The Patent Toolbox: Arrowhead has acquired or
exclusively licensed patents and patent applications
covering a broad range of nanotechnology. The Company
is actively seeking to add to this intellectual property
portfolio.
Safe Harbor Statement under the Private Securities
Litigation Reform Act of 1995:
This
news release contains forward-looking statements
within the meaning of the "safe harbor" provisions
of the Private Securities Litigation Reform Act of
1995. These statements are based upon our current
expectations and speak only as of the date hereof.
Our actual results may differ materially and adversely
from those expressed in any forward-looking statements
as a result of various factors and uncertainties,
including the recent economic slowdown affecting
technology companies, the future success of our scientific
studies, our ability to successfully develop products,
rapid technological change in our markets, changes
in demand for our future products, legislative, regulatory
and competitive developments and general economic
conditions. Our Annual Report on Form 10-K and 10-K/A,
recent and forthcoming Quarterly Reports on Form
10-Q and 10-Q/A, recent Current Reports on Forms
8-K and 8-K/A, our Registration Statement on Form
S-3, and other SEC filings discuss some of the important
risk factors that may affect our business, results
of operations and financial condition. We undertake
no obligation to revise or update publicly any forward-looking
statements for any reason.
|